Giacomin Jon L
CEO, Medical Segment at CAH
- Sold, on record
- $6.3M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Aug 20, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CAHCARDINAL HEALTH INCCEO, Medical Segment
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CAHUnusualAug 16, 2016 2016
Sold 47,251 shares at $82.77 ($3.9M)
Giacomin Jon L, CEO, Pharmaceutical Segment
Sold 58.9% of holdings ($6.6M position)33,015 shares leftFirst sale on recordFiling
- 2 Form 4 sale CAHUnusualMay 12, 2017 +269 days
Sold 23,270 shares at $72.87 ($1.7M)
Giacomin Jon L, CEO, Pharmaceutical Segment
Sold 42% of holdings ($4M position)32,170 shares leftFiling
- 3 Form 4 sale CAHPlan not statedFeb 20, 2018 +284 days
Sold 7,995 shares at $68.78 ($550k)
Giacomin Jon L, CEO, Medical Segment
Sold 12.7% of holdings ($4.3M position)55,048 shares leftFiling
- 4 Form 4 sale CAHPlan not statedAug 20, 2018 +181 days
Sold 2,890 shares at $51.95 ($150k)
Giacomin Jon L, CEO, Medical Segment
Sold 3.8% of holdings ($3.9M position)72,652 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2018 | Aug 21, 2018 | CAH | CEO, Medical Segment | Form 4 sale | 2,890 | $150k | 3.8% | Plan not stated | SEC |
| Feb 20, 2018 | Feb 20, 2018 | CAH | CEO, Medical Segment | Form 4 sale | 7,995 | $550k | 12.7% | Plan not stated | SEC |
| May 12, 2017 | May 15, 2017 | CAH | CEO, Pharmaceutical Segment | Form 4 sale | 23,270 | $1.7M | 42.0% | Unusual | SEC |
| Aug 16, 2016 | Aug 17, 2016 | CAH | CEO, Pharmaceutical Segment | Form 4 sale | 47,251 | $3.9M | 58.9% | Unusual | SEC |